Constellation Pharmaceuticals (CNST) Prices 5.5M Share Common Offering at $35/Sh

Constellation Pharmaceuticals, Inc., (NASDAQ: CNST) today announced that it has priced an underwritten public offering of 5,500,000 shares of its common stock at a public offering price of $35.00 per share, for total gross proceeds of $192.5 million, before deducting underwriting discounts and commissions and expenses payable by Constellation. All of the shares in the offering are being sold by Constellation. In addition, Constellation has granted the underwriters a 30-day option to purchase up to 825,000 additional shares of its common stock at the public offering price, less the underwriting discount and commissions. The offering is expected to close on June 19, 2020, subject to customary closing conditions.

J.P. Morgan, Jefferies, Cowen and RBC Capital Markets are acting as joint book-running managers for the offering. SunTrust Robinson Humphrey is acting as lead manager and Baird is acting as co-manager for the offering.

The shares are being offered by Constellation pursuant to an automatically effective shelf registration statement that was filed with the Securities and Exchange Commission (“SEC”) on December 9, 2019.

You May Also Be Interested In

• Alliance Laundry principal stockholder prices 22.55M share offering
• Datavault AI agrees to acquire Wyoming bank BankWyse
• Wrap Technologies closes $12M stock offering at $1.40 per share